TNF-α blockade impairs in vitro tuberculous granuloma formation and down modulate Th1, Th17 and Treg cytokines
- PMID: 29543912
- PMCID: PMC5854376
- DOI: 10.1371/journal.pone.0194430
TNF-α blockade impairs in vitro tuberculous granuloma formation and down modulate Th1, Th17 and Treg cytokines
Abstract
Tuberculosis (TB) is a granulomatous disease that has affected humanity for thousands of years. The production of cytokines, such as IFN-γ and TNF-α, is fundamental in the formation and maintenance of granulomas and in the control of the disease. Recently, the introduction of TNF-α-blocking monoclonal antibodies, such as Infliximab, has brought improvements in the treatment of patients with chronic inflammatory diseases, but this treatment also increases the risk of reactivation of latent tuberculosis. Our objective was to analyze, in an in vitro model, the influence of Infliximab on the granulomatous reactions and on the production of antigen-specific cytokines (TNF-α, IFN-γ, IL-12p40, IL-10 and IL-17) from beads sensitized with soluble Bacillus Calmette-Guérin (BCG) antigens cultured in the presence of peripheral blood mononuclear cells (PBMC) from TB patients. We evaluated 76 individuals, with tuberculosis active, treated and subjects with positive PPD. Granuloma formation was induced in the presence or absence of Infliximab for up to 10 days. The use of Infliximab in cultures significantly blocked TNF-α production (p <0.05), and led to significant changes in granuloma structure, in vitro, only in the treated TB group. On the other hand, there was a significant reduction in the levels of IFN-γ, IL-12p40, IL-10 and IL-17 after TNF-α blockade in the three experimental groups (p <0.05). Taken together, our results demonstrate that TNF-α blockade by Infliximab directly influenced the structure of granuloma only in the treated TB group, but negatively modulated the production of Th1, Th17 and regulatory T cytokines in the three groups analyzed.
Conflict of interest statement
Figures





Similar articles
-
Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.Arthritis Rheum. 2003 Mar;48(3):780-90. doi: 10.1002/art.10847. Arthritis Rheum. 2003. PMID: 12632433
-
[The effect of interleukin-7 and interleukin-15 on the production of Th1 and Th2 cytokines by peripheral blood mononuclear cells from patients with tuberculosis].Zhonghua Jie He He Hu Xi Za Zhi. 2006 Jun;29(6):403-6. Zhonghua Jie He He Hu Xi Za Zhi. 2006. PMID: 17045026 Chinese.
-
Th1 responses are more susceptible to infliximab-mediated immunosuppression than Th17 responses.Dig Dis Sci. 2011 Dec;56(12):3525-33. doi: 10.1007/s10620-011-1780-1. Epub 2011 Jun 16. Dig Dis Sci. 2011. PMID: 21678051
-
[The role of Th1, Th17, and Treg cells in the pathogenesis of rheumatoid arthritis including anti-inflammatory action of Th1 cytokines].Postepy Hig Med Dosw (Online). 2011 Jun 17;65:397-403. doi: 10.5604/17322693.948971. Postepy Hig Med Dosw (Online). 2011. PMID: 21734324 Review. Polish.
-
Reactivation of latent tuberculosis by TNF blockade: the role of interferon gamma.J Investig Dermatol Symp Proc. 2007 May;12(1):16-21. doi: 10.1038/sj.jidsymp.5650031. J Investig Dermatol Symp Proc. 2007. PMID: 17502864 Review.
Cited by
-
The Interplay Between Systemic Inflammation, Oxidative Stress, and Tissue Remodeling in Tuberculosis.Antioxid Redox Signal. 2021 Feb 20;34(6):471-485. doi: 10.1089/ars.2020.8124. Epub 2020 Jun 19. Antioxid Redox Signal. 2021. PMID: 32559410 Free PMC article. Review.
-
Comparative Effects of Turmeric Secondary Metabolites Across Resorptive Bone Diseases.Metabolites. 2025 Apr 11;15(4):266. doi: 10.3390/metabo15040266. Metabolites. 2025. PMID: 40278395 Free PMC article.
-
Assessment of Experimental Techniques That Facilitate Human Granuloma Formation in an In Vitro System: A Systematic Review.Cells. 2022 Mar 2;11(5):864. doi: 10.3390/cells11050864. Cells. 2022. PMID: 35269486 Free PMC article.
-
Bovine Immunity and Vitamin D3: An Emerging Association in Johne's Disease.Microorganisms. 2022 Sep 18;10(9):1865. doi: 10.3390/microorganisms10091865. Microorganisms. 2022. PMID: 36144467 Free PMC article. Review.
-
Tuberculosis and diabetes mellitus: Relating immune impact of co-morbidity with challenges in disease management in high burden countries.J Clin Tuberc Other Mycobact Dis. 2022 Nov 29;29:100343. doi: 10.1016/j.jctube.2022.100343. eCollection 2022 Dec. J Clin Tuberc Other Mycobact Dis. 2022. PMID: 36478777 Free PMC article.
References
-
- Alsdurf H, Hill PC, Matteelli A, Getahun H, Menzies D (2016) The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis 16: 1269–1278. doi: 10.1016/S1473-3099(16)30216-X - DOI - PubMed
-
- Hartman-Adams H, Clark K, Juckett G (2014) Update on latent tuberculosis infection. Am Fam Physician 89: 889–896. - PubMed
-
- Eurosurveillance editorial t (2013) WHO publishes Global tuberculosis report 2013. Euro Surveill 18. - PubMed
-
- Caruso AM, Serbina N, Klein E, Triebold K, Bloom BR, et al. (1999) Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol 162: 5407–5416. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources